Access Resources
4251 - 4260 of 7540 Results
Title
Year
- Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's diseaseJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 871Issue #:Start Page: 172914End Page: 172914Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172914Citation Count: 13
-
RESTRICTEDTitle: Organoid Cultures as Preclinical Models of Non–Small Cell Lung CancerJournal Name: Clinical Cancer ResearchPublisher: American Association for Cancer Research (AACR)Vol: 26Issue #: 5Start Page: 1162End Page: 1174Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1158/1078-0432.ccr-19-1376Best OA location URL: https://clincancerres.aacrjournals.org/content/clincanres/26/5/1162.full.pdfCitation Count: 147
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia2020RESTRICTEDTitle: Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementiaJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 26Issue #: 3Start Page: 379End Page: 386Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-020-0755-1Best OA location URL: https://discovery.ucl.ac.uk/10093347/3/Zetterberg_Janelidze.pdfCitation Count: 642
- Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s disease2020RESTRICTEDTitle: Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s diseaseJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 103Issue #:Start Page: 101807End Page: 101807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.artmed.2020.101807Citation Count: 21
-
RESTRICTEDTitle: Social Impact of Connected Landmark Lighting: A Social Sensing ApproachJournal Name: IEEE Internet of Things MagazinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 3Issue #: 1Start Page: 64End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/iotm.0001.1900088Citation Count: 1
- The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease2020RESTRICTEDTitle: The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 3Start Page: 295End Page: 295Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.3983Citation Count: 11
-
RESTRICTEDTitle: Three-Plane–assembled Deep Learning Segmentation of GliomasJournal Name: Radiology: Artificial IntelligencePublisher: Radiological Society of North America (RSNA)Vol: 2Issue #: 2Start Page: e190011End Page: e190011Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1148/ryai.2020190011Best OA location URL: https://pubs.rsna.org/doi/pdf/10.1148/ryai.2020190011Citation Count: 17
-
RESTRICTEDTitle: β-adrenoreceptors and the risk of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 247End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4Citation Count: 44
- An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases2020RESTRICTEDTitle: An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative DiseasesJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 3Start Page: 576End Page: 576Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9030576Best OA location URL: https://www.mdpi.com/2073-4409/9/3/576/pdf?version=1585198756Citation Count: 20
- Outcome measurement in functional neurological disorder: a systematic review and recommendations2020RESTRICTEDTitle: Outcome measurement in functional neurological disorder: a systematic review and recommendationsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 6Start Page: 638End Page: 649Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2019-322180Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/6/638.full.pdfCitation Count: 74